BlackRock’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

BlackRock’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50	Closed	–	–	5713
2026 Q1	$0	Hold	50	–	–	﹤0.01%	5692
2025 Q4	$5	Hold	50	–	–	﹤0.01%	5519
2025 Q3	$10	Hold	50	–	–	﹤0.01%	5435
2025 Q2	$11	Hold	50	–	–	﹤0.01%	5439
2025 Q1	$11	Buy	+50	New	+$17	﹤0.01%	5409

BlackRock's SRTAW Position: Q2 2026 in Review

BlackRock sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2026, closing a stake of 50 shares.

BlackRock first reported a position in SRTAW in Q1 2025 and held it in 5 quarters. The position peaked at $11 in Q2 2025. 0 funds tracked by Wall St. Rank hold SRTAW as of Q2 2026.

BlackRock reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2026 after selling out during the quarter.
BlackRock sold 50 Strata Critical Medical Inc Warrants shares in Q2 2026.
BlackRock first reported a position in Strata Critical Medical Inc Warrants in Q1 2025 and held it in 5 quarters.
BlackRock's Strata Critical Medical Inc Warrants position peaked at $11 in Q2 2025.
0 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.